David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents

Vapotherm is a publicly traded developer and manufacturer of advanced respiratory technology.

David discusses Good Law Project's High Court application for permission to challenge the Human Medicines (Amendment) Regulations 2019.

A comprehensive programme launched during the Unbound Festival in Bahrain, for start-ups, SMEs and entrepreneurs.

Welcome to the Marchedition of our Pharmacy Brief.